Skip to main content

Table 3 Variables evaluated at baseline and follow-up (4.9 ± 3.63 years)

From: A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity

 

Surgery (n = 154)

p

Nonsurgical (n = 360)

p

Baseline

Follow-up

Baseline

Follow-up

Age (years)

41.0 ± 10.13

–

–

42.2 ± 12.94

–

–

BMI (kg/m2)

42.7 ± 4.62

36.7 ± 5.24

0.0001

39.1 ± 5.27

39.1 ± 6.16

0.5047

Blood glucose (mg/dL)

108.6 ± 39.36

97.6 ± 32.09

0.0001

103.1 ± 27.40

103.6 ± 30.47

0.4452

Hba1c (%)

6.0 ± 1.35

5.5 ± 1.01

0.0001

7.6 ± 2.51

6.7 ± 1.64

0.1055

Systolic BP (mmHg)

133.8 ± 14.59

127.2 ± 12.38

0.0001

132.4 ± 13.36

132.8 ± 8.76

0.9090

Diastolic BP (mmHg)

83.9 ± 9.55

77.8 ± 8.68

0.0001

78.65 ± 9.48

78.8 ± 10.43

0.5203

Heart rate (bpm)

78.2 ± 5.95

55.7 ± 28.89

0.0304

71.2 ± 6.46

75.8 ± 10.56

0.1280

EGFR (mL/min/1.73 m2)

107.3 ± 29.07

99.3 ± 23.34

0.0010

85.4 ± 21.54

90.2 ± 18.83

0.0811

Cholesterol (mg/dL)

207.7 ± 43.77

203.2 ± 36.77

0.0685

210.5 ± 32.68

198.8 ± 37.43

0.0272

LDL-cholesterol (mg/dL)

130.6 ± 40.50

124.44 ± 32.60

0.0250

135.4 ± 35.07

119.3 ± 34.81

0.0214

HDL-cholesterol (mg/dL)

50.1 ± 13.52

54.6 ± 13.87

0.0001

48.4 ± 11.82

51.29 ± 12.29

0.0298

Triglycerides (mg/dL)

140.4 ± 76.49

122.2 ± 66.93

0.0001

139.2 ± 68.34

130.8 ± 52.72

0.1735

AST (U/L)

23.7 ± 11.86

21.5 ± 8.55

0.0146

23.6 ± 10.41

24.5 ± 7.26

0.2830

ALT (U/L)

31.3 ± 21.14

24.2 ± 15.39

0.0001

32.9 ± 27.64

30.4 ± 15.19

0.2568

  1. Mean ± SD
  2. BMI body mass index, HbA1c glycated hemoglobin, EGFR estimated glomerular filtration rate (mL/min/1.73 m2), AST aspartate transaminase, ALT alanine transaminase